Cancer

red and blue boxing gloves
March 5, 2020

One-two punch for cancer

A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.

By Sanjay Mishra
Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Maylee Wilshire served as Mayor of Smashville at the recent Nashville Predators Hockey Fights Cancer Night. Here, Wilshire drops the puck with Predators’ captain Roman Josi, left, and Columbus Blue Jackets’ captain Nick Foligno. Hockey Fights Cancer provides an opportunity to bring special guests from Children’s Hospital to Bridgestone Arena and to let the young hockey fans have a one-of-a-kind experience with the Nashville Predators. All money raised during the games benefits the 365 Pediatric Cancer Fund at Children’s Hospital to support childhood cancer initiatives.
March 5, 2020

Hockey Fights Cancer

Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Maylee Wilshire served as Mayor of Smashville at the recent Nashville Predators Hockey Fights Cancer Night.

By VUMC News and Communications
Dona Potter was treated with a new immunotherapy that entails re-engineering a patient’s T cells to target cancer.
February 27, 2020

Patient’s cancer treatment includes new immunotherapy

Dona Potter, 87, rode Harleys and drove 18-wheelers back when men dominated the open highways, and she is still defying expectations.

By Tom Wilemon
February 27, 2020

Breast cancer study may help predict treatment response

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.

By Bill Snyder
February 20, 2020

Discovery Lecture to feature head and neck cancer expert Grandis

By Leigh MacMillan
February 13, 2020

Advocacy group’s gift boosts lung cancer research efforts

An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

By Tom Wilemon
February 10, 2020

Imaging breast cancer cell size

A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.
By Leigh MacMillan
February 6, 2020

Powering H. pylori pathogenesis

Timothy Cover and colleagues report new insights into the sources of energy used by a bacterial “machine” linked to the pathogenesis of stomach cancer.
By Leigh MacMillan
February 5, 2020

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.
By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.
By Tom Wilemon
January 29, 2020

Protein research seeks to induce tumor regression

Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks.
By Bill Snyder
January 23, 2020

HDL-cholesterol and breast cancer risk

Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.
By Leigh MacMillan
January 23, 2020

Study examines prostate cancer treatment decisions

A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.
By Craig Boerner